четверг, 1 марта 2012 г.
Fed: Drugs expert on committee could restrict debate
AAP General News (Australia)
02-07-2001
Fed: Drugs expert on committee could restrict debate
There's concern in medical circles the appointment of a former drug industry executive
to the Pharmaceutical Benefits Advisory Committee could lead to a potential conflict of
interest.
Former committee member Dr SIAN HUGHES says having drug interests on the committee
could restrict debate over drugs that are being considered for government subsidies.
Earlier this month, the Federal Government overhauled its 12 person committee.
One of the new appointees is PAT CLEAR, a …
Подписаться на:
Комментарии к сообщению (Atom)

Комментариев нет:
Отправить комментарий